Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada.
Katherine J LepikOlivia L HuntNic BacaniLu WangMarianne HarrisJunine ToyTaylor McLindenPaul SeredaLinda J AkagiErin ReadyJulio Sg MontanerRolando BarriosPublished in: Antiviral therapy (2024)
Generic substitution of antiretrovirals for HIV-Tx and PrEP was well tolerated, with ≤2% incidence of mild-moderate PSI ADRs.